You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 12, December 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Paper
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (41)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Burns
 •Surgical Cytokines
 •Immunology
 •Immunology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Protective Effects of Early Interleukin 10 Antagonism on Injury-Induced Immune Dysfunction

Ann Lyons, MB, BCh; Andreas Goebel, MD, PhD; John A. Mannick, MD; James A. Lederer, PhD

Arch Surg. 1999;134:1317-1324.

Hypothesis  Interleukin 10 (IL-10) plays a central role in the development of postinjury immune suppression, and early in vivo IL-10 antagonism can be protective.

Design  Male A/J mice underwent sham or burn injury and were treated with monoclonal anti–IL-10 antibody or control antibody at 1 day or 3 days after injury. Their ability to survive polymicrobial sepsis induced by the cecum ligation and puncture (CLP) technique was then tested. The response of sham- and burn-injured mice and burn-injured mice treated with anti–IL-10 to immunization with a T-cell–dependent antigen, trinitrophenyl (TNP)–haptenated ovalbumin (TNP-OVA) was also assessed.

Main Outcome Measures  Mortality was monitored for a total of 7 days after CLP to assess the effect of anti–IL-10 therapy on the survival of burn-injured, immune-compromised mice. Serum antibody isotype formation was measured in sham- and burn-injured mice and burn-injured mice treated with anti–IL-10 to determine how IL-10 antagonism influenced helper T-cell responses in vivo. In vitro cytokine production by antigen-stimulated spleen cells was assessed to study the effect of blocking IL-10 activity at 1 day vs 3 days after burn injury.

Results  Treating mice with anti–IL-10 at 1 day after injury significantly improved CLP survival, whereas delaying treatment 3 days had no beneficial effect. The analysis of T-cell function in vivo as determined by serum antibody isotype formation indicated that anti–IL-10 treatment at 1 day or 3 days after injury increased T helper cell 1–type antibody formation to sham injury levels by day 10. Moreover, these treatments restored the injury-induced reduction of antigen-stimulated IL-2, interferon {gamma}, and IL-10 production.

Conclusions  Interleukin 10 plays an early role in the development of burn injury–induced immune suppression. Its in vivo inhibition at 1 day after injury may be a useful approach toward preventing the development of injury-induced immune dysfunction and may do so by restoring T-cell function and cytokine production.


From the Department of Surgery, Section of Immunology, Harvard Medical School, Brigham and Women's Hospital, Boston, Mass.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis
Scumpia et al.
Blood 2007;110:3673-3681.
ABSTRACT | FULL TEXT  

Lysozyme-Modified Probiotic Components Protect Rats against Polymicrobial Sepsis: Role of Macrophages and Cathelicidin-Related Innate Immunity
Bu et al.
J. Immunol. 2006;177:8767-8776.
ABSTRACT | FULL TEXT  

Platelet depletion in mice increases mortality after thermal injury
Fujimi et al.
Blood 2006;107:4399-4406.
ABSTRACT | FULL TEXT  

Enhanced Regulatory T Cell Activity Is an Element of the Host Response to Injury
Choileain et al.
J. Immunol. 2006;176:225-236.
ABSTRACT | FULL TEXT  

Enhancement of Dendritic Cell Production by Fms-Like Tyrosine Kinase-3 Ligand Increases the Resistance of Mice to a Burn Wound Infection
Toliver-Kinsky et al.
J. Immunol. 2005;174:404-410.
ABSTRACT | FULL TEXT  

Gamma Interferon Does Not Enhance Clearance of Pseudomonas aeruginosa but Does Amplify a Proinflammatory Response in a Murine Model of Postseptic Immunosuppression
Murphey et al.
Infect. Immun. 2004;72:6892-6901.
ABSTRACT | FULL TEXT  

Role of IL-10 in regulating proinflammatory cytokine release by Kupffer cells following trauma-hemorrhage
Yokoyama et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2004;286:G942-G946.
ABSTRACT | FULL TEXT  

Burn Injury Initiates a Shift in Superantigen-Induced T Cell Responses and Host Survival
Zang et al.
J. Immunol. 2004;172:4883-4892.
ABSTRACT | FULL TEXT  

Burn Injury Promotes Antigen-Driven Th2-Type Responses In Vivo
Guo et al.
J. Immunol. 2003;171:3983-3990.
ABSTRACT | FULL TEXT  

Genotype and interleukin-10 responses after cardiopulmonary bypass{dagger}
Galley et al.
Br J Anaesth 2003;91:424-426.
ABSTRACT | FULL TEXT  

Role of Interleukin-10 in the Intracellular Sequestration of Human Leukocyte Antigen-DR in Monocytes during Septic Shock
Fumeaux and Pugin
Am. J. Respir. Crit. Care Med. 2002;166:1475-1482.
ABSTRACT | FULL TEXT  

IFN-{gamma} Production from Liver Mononuclear Cells of Mice in Burn Injury As Well As in Postburn Bacterial Infection Models and the Therapeutic Effect of IL-18
Ami et al.
J. Immunol. 2002;169:4437-4442.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.